Insmed | Spese Operative



Operating Expenses Cambiamento Data
BioMarin Pharmaceutical USD 548.52M 27.27M 2025-06
Cytokinetics USD 178.28M 21.06M 2025-06
DBV Technologies USD 27.37M 3M 2025-03
Dynavax Technologies USD 81.01M 10.78M 2025-06
Gilead Sciences USD 4.35B 80M 2025-06
Insmed USD 361.29M 20.33M 2025-06
Novartis USD 10.15B 579M 2024-12
Regeneron Pharmaceuticals USD 2.6B 159.1M 2025-06
Sarepta Therapeutics USD 495.51M 549.73M 2025-06
Ultragenyx Pharmaceutical USD 274.38M 7.85M 2025-06
Vertex Pharmaceuticals USD 1.81B 71.4M 2025-06


Insmed Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.